Furthermore, emodin activates PPAR, thus affecting the expression of downstream genes FABPs (ap2) and resistin, among which, ap2 plays a critical role in dyslipidemia, IR, and atherosclerosis in humans. This evidence concerns the gene PPARA and metabolic syndrome.